Supplementary protection
LT - 1-((5-heteroariltiazol-2-il)aminokarbonil)pirolidin-2-karboksamido dariniai, kaip fosfatidilinozitolio 3-kinazės (PI3K) inhibitoriai, naudingi proliferacinių ligų gydyme
EN - 1-((5-HETEROARYLTHIAZOL-2-YL)AMINOCARBONYL)PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITORS USEFUL IN THE TREATMENT OF PROLIFERATIVE DISEASES
SPC
| (11) |
Number of the document |
C 2331537 |
| (68) |
Number of the document |
2331537
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2020 534 |
| (22) |
Date of filing the application |
2020-11-25 |
| (41) |
Date of publication of the application |
2020-12-28 |
|
Date of publication of SPC |
2022-01-10 |
| (24) |
Date of coming into effect of SPC |
2029-09-09 |
Applicant
| (71) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
Grantee
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/20/1455, 2020-07-27
|
Calculated date of expiry of the SPC
| (94) |
2034-09-08 |
Name of the product protected by the basic patent
| (95) |
Alpelisibas arba jo druska |
